Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jul;54(7):1684-92.
doi: 10.1007/s00125-011-2122-8. Epub 2011 Apr 12.

HLA-DRB1 reduces the risk of type 2 diabetes mellitus by increased insulin secretion

R C Williams  1 , Y L Muller, R L Hanson, W C Knowler, C C Mason, L Bian, V Ossowski, K Wiedrich, Y F Chen, S Marcovina, J Hahnke, R G Nelson, L J Baier, C Bogardus
Affiliations

HLA-DRB1 reduces the risk of type 2 diabetes mellitus by increased insulin secretion

R C Williams et al. Diabetologia. 2011 Jul.

Abstract

Aims/hypothesis: We sought to identify the physiological implications of genetic variation at the HLA-DRB1 region in full-heritage Pima Indians in Arizona.

Methods: Single-nucleotide polymorphisms from the HLA region on chromosome 6p were tested for association with skeletal muscle mRNA expression of HLA-DRB1 and HLA-DRA, and with type 2 diabetes mellitus and prediabetic traits.

Results: The A allele at rs9268852, which tags HLA-DRB1 02(1602), was associated both with higher HLA-DRB1 mRNA expression (n = 133, p = 4.27 × 10(-14)) and decreased risk of type 2 diabetes (n = 3,265, OR 0.723, p = 0.002). Among persons with normal glucose tolerance (n = 266) this allele was associated with a higher mean acute insulin response during an intravenous glucose tolerance test (p = 0.005), higher mean 30 min insulin concentration during an oral glucose tolerance test (p = 0.017) and higher body fat percentage (p = 0.010). The polymorphism was not associated with HLA-DRA mRNA expression or insulin sensitivity.

Conclusions/interpretation: HLA-DRB1*02 is protective for type 2 diabetes, probably by enhancing self tolerance, thereby protecting against the autoimmune-mediated reduction of insulin secretion.

PubMed Disclaimer

Conflict of interest statement

Duality of interest The authors declare that there is no duality of interest associated with this manuscript.

Figures

Fig. 1
Fig. 1
Mean concentrations of insulin (a) and glucose (b) in 266 participants with normal glucose tolerance stratified by the presence (squares) or absence (triangles) of HLA-DRB1*02(1602) (n=33) during an IVGTT. Insulin secretion was higher for persons with DRB1*02 during the test. After adjusting for age, sex, body fat percentage and insulin sensitivity, AIR was higher in persons with DRB1*02 (p=0.005, Table 4)
Fig. 2
Fig. 2
Plasma concentrations of insulin (a) and glucose (b) after a 75 g OGTT in 266 participants with normal glucose tolerance stratified by the presence (squares) or absence (triangles) of HLA-DRB1* 02(1602). After adjusting for covariates age, sex, body fat percentage, 30 min glucose and insulin sensitivity, the 30 min insulin concentration was higher (p=0.017, Table 4) for those with DRB1*02
See this image and copyright information in PMC

References

    1. Knowler WC, Pettitt DJ, Saad MF, Bennett PH (1990) Diabetes mellitus in the Pima Indians: incidence risk factors and pathogenesis. Diab Metab Rev 6:1–27 - PubMed
    1. Lillioja S, Mott DM, Spraul M et al. (1993) Insulin resistance and insulin secretory dysfunction as precursors of non-insulin dependent diabetes mellitus: prospective studies in Pima Indians. N Engl J Med 329:1988–1992 - PubMed
    1. Weyer C, Tataranni PA, Bogardus C, Pratley RE (2001) Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. Diab Care 24:89–94 - PubMed
    1. Weyer C, Bogardus C, Mott DM, Pratley RE (1999) The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes. J Clin Invest 104:787–794 - PMC - PubMed
    1. Williams RC, McAuley JE (1992) HLA class I variation controlled for genetic admixture in the Gila River Indian Community of Arizona: a model for the Paleo-Indians. Hum Immunol 33:39–46 - PubMed

Publication types